Survival analysis in breast cancer using proteomic data from four independent datasets
Abstract Breast cancer clinical treatment selection is based on the immunohistochemical determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to correlate immunohistochemical results to proteome-level technologies in measuring the expression of these markers. We also aime...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/98b06f65bfd74ceea979747b3df6d25b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|